SherryLeeBrahenyMDMS

PubMed

• 12 citations
  Immunological complications in multiple sclerosis patients receiving interferon.
  George P. A. Rice, E. L. Woelfel, Pierre J. Talbot, Sherry L. Braheny, Jack C. Sipe, Robert L. Knobler, Thomas C. Merigan, Michael B. A. Oldstone> ;Annals of Neurology. 1985 Oct 1
• 30 citations
  Endoneurial injection of antisera to myelin antigens.
  Richard A. C. Hughes, Henry C. Powell, S. L. Braheny, Steven W. Brostoff> ;Muscle & Nerve. 1985 Jul 1
• 8 citations
  The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease activity in patients with multiple sclerosis.
  George P. A. Rice, Jack C. Sipe, Sherry L. Braheny, Robert L. Knobler, David A. Finney, Michael B. A. Oldstone> ;Annals of the New York Academy of Sciences. 1984 Dec 1
• 11 citations
  Clinical trial of natural alpha interferon in multiple sclerosis.
  Robert L. Knobler, Hillel S. Panitch, Sherry L. Braheny, Jack C. Sipe, George P. A. Rice, John R. Huddlestone, Gordon S. Francis, Carol J. Hooper, Roberta Kamin-Lewis,...> ;Annals of the New York Academy of Sciences. 1984 Dec 1
• 96 citations
  Systemic alpha‐interferon therapy of multiple sclerosis
  Robert L. Knobler, Hillel Panitch, Sherry L. Braheny, Jack C. Sipe, George P. A. Rice, John R. Huddlestone, Gordon S. Francis, Carol J. Hooper, Roberta Kamin-Lewis, Ke...> ;Neurology. 1984 Oct 1
• 195 citations
  A neurologic rating scale (NRS) for use in multiple sclerosis
  Jack C. Sipe, Robert L. Knobler, Sherry L. Braheny, George P. A. Rice, Hillel S. Panitch, Michael B. A. Oldstone> ;Neurology. 1984 Oct 1
• 47 citations
  Disease activity markers in multiple sclerosis Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8
  George P. A. Rice, David A. Finney, Sherry L. Braheny, Robert L. Knobler, Jack C. Sipe, Michael B. A. Oldstone> ;Journal of Neuroimmunology. 1984 Apr 1
• 21 citations
  Antigen-specific demyelination and significance of the bystander effect in peripheral nerves.
  Henry C. Powell, S. L. Braheny, R A Hughes, Peter W. Lampert> ;The American Journal of Pathology. 1984 Mar 1
• 69 citations
  Early changes in experimental allergic neuritis
  Henry C. Powell, S. L. Braheny, Robert R. Myers, Moses Rodriguez, Peter W. Lampert> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 1983 Mar 1
• 7 citations
  Myasthenia gravis: in vitro immunoglobulin production with pokeweed mitogen challenge and B- and T-lymphocyte competence.
  Bengt Harfast, John R. Huddlestone, Sherry L. Braheny, Marjorie E. Seybold, Michael B. A. Oldstone> ;Clinical Immunology and Immunopathology. 1981 Sep 1
• Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis.
  Huddlestone, J. R., Sipe, J., Braheny, S., Jensen, F. C., McMillan, R., Lampert, P., Oldstone, M. B.> ;Lancet. 1979 Aug 25
• Join now to see all

Journal Articles

• Immunological Complications in Multiple Sclerosis Patients Receiving Interferon  
  Rice, G.P., Woelfel, E.L., Talbot, P.J., Braheny, S.L., Sipe, J.C., Knobler, R.L., Merigan, T.C., Oldstone, M.B., Ann. Neurol., 1/1/1985
• Clinical Trial of Natural Alpha-Interferon in Multiple Sclerosis  
  Knobler, R.L., Panitch, H.S., Braheny, S.L., Sipe, J.C., Rice, G.P., Huddlestone, J.R., Francis, G.S., Hooper, C.J., Kamin-Lewis, R.M., Johnson, K.P., et al, Ann. NY Acad. Sci., 1/1/1984
• Systematic Alpha-Interferon Therapy of Multiple Sclerosis  
  Knobler, R.L., Panitch, H.S., Braheny, S.L., Sipe, J.C., Rice, G.P., Huddleston, J.R., Francis, G.S., Hooper, C.J., Kamin-Lewis, R.M., Johnson, K.P., et al, Neurology, 1/1/1984
• Antigen Specific Demyelination and Significance of the Bystander Effect in Peripheral Nerves  
  Powell, H.C., Braheny, S.L., Hughes, R.A., Lampert, P.W., Am. J. Pathol., 1/1/1984
• The Failure of Monoclonal Antibody Defined Lymphocyte Subsets to Monitor Disease Activity in Patients with Multiple Sclerosis  
  Rice, G.P., Sipe, J.C., Braheny, S.L., Knobler, R.L., Finnery, D.A., Oldstone, M.B., Ann NY Acad. Sci., 1/1/1984
• Disease Activity Markers in Multiple Sclerosis Another Look at Suppressor Cells Defined by Monoclonal Antibodies OKT4, OKT5, and OKT8  
  Rice, G.P., Finney, D., Braheny, S.L., Knobler, R.L., Sipe, J.C., Oldstone, M.B., J. Neuroimmunol, 1/1/1984
• Early Changes in Experimental Allergic Neuritis  
  Powell, H.C., Braheny, S.L., Myers, R.R., Rodriguez, M., Lampert, P.W., Lab. Invest., 1/1/1983
• Myasthenia Gravis: In Vitro Immunoglobulin Production with Pokeweed Mitogen Challenge and B-and T-lymphocyte Competence  
  Harfast, B., Huddlestone, J.R., Braheny, S.L., Seybold, M.E., Oldstone, M.B., Clini, Immunol, and Immunopath, 1/1/1981
• Join now to see all

Books/Book Chapters

• The Picture of Health - Medical Ethics and the Movies Part four: communication and provider-patient relationships 
  Chapter: #8 integrity and boundary setting: antwone fisher 
  Page 192 - 196Sherry Braheny, M.D.Editors: Henri Colt, Silvia Quadrelli, and Lester Friedman.Oxford University Press, Inc., New York2011
• Experimental and Clinical Neurotoxicology 
  Chapter: Tellerium 
  Page 118 - 138Braheny, S.L., Lampert, P.W.Editors: P.S. Spencer and H.H. Schaumber.. The Williams and Wilkins Co., Baltimore1980
• Current Topics in Nerve and Muscle Research (Congress Series) 
  Chapter: Neuropathies Caused by Myelinotoxic Agents 
  Page 292 - 298Lampert, P.W., Braheny, S.L., Powell, H.C.Editors: A.M. Aguayo and K.Karpati.Excerpta Medica, Inc.1979

Abstracts/Posters

• Broca's Bones.
  Braheny, S.L., Amer. Acad. Neurology, 50th Annual Meeting, 1/1/1998